tranexamic acid
Pre-clinical- Indications
- Cancer
Company intelligence / Profile preview
Tranexamic Technologies
Dallas, Texas, United Statestxatechnology.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Tranexamic Technologies has developed a new class of drugs—TXCAs—based on the broader antagonism properties of tranexamic acid beyond antifibrinolysis. Their pipeline includes candidates for oncology, infectious diseases, trauma/concussion care, cosmetic recovery, and healthspan extension. Several programs are entering or in clinical trials; others are in late preclinical development.
- Therapeutic areas
- OncologyMetabolic DisordersDermatologyNeurologyInfectious Diseases
- Modalities
- Small molecules (Tranexamic Acid analogs and derivatives)Topical gelsNasal spraysOral medications
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Johnson & Johnson Innovation JLABS residency since April 2024.
Beyond the preview
Go deeper on Tranexamic Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tranexamic Technologies.